Results 151 to 160 of about 57,710 (262)

It's Here, It's There, There's Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis. [PDF]

Infect Dis Ther
Keck JM, Dare RK, Jenkins MB, Rico JC, Grisham L, McDonald J, Viteri A, Bradsher RW.   +7 more
europepmc   +1 more source

Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge [PDF]

, 1979
L M Pope, Garry T. Cole, M. Neal Guentzel, L. Joe Berry   +3 more
openalex   +1 more source

Candidiasis

Medical Mycology Journal, 2011
openaire   +3 more sources

Urinothorax With Fungal Empyema—A Rare and Unique Combination

Respirology Case Reports, Volume 13, Issue 4, April 2025.
This case describes a patient presenting with symptomatic unilateral pleural effusion after a urological procedure which was initially treated and resolved. It subsequently recurred and was complicated by fungal pleural infection. It was treated as urinothorax.
Muhammad Redzwan S. Rashid Ali, Tham Teck Meng   +1 more
wiley   +1 more source

Genetic susceptibility to recurrent vulvovaginal candidiasis in an African population from Nairobi, Kenya. [PDF]

Sci Rep
Omosa-Manyonyi GS, Ponce IR, Rosati D, Bruno M, Kamau NW, Obimbo MM, Jaeger M, van der Ven AJAM, Netea MG, Kumar V, Oever JT.   +10 more
europepmc   +1 more source

Gastrointestinal candidiasis in rats treated with antibiotics, cortisone, and azathioprine [PDF]

, 1976
Alfred DeMaria, H R Buckley, Franz von Lichtenberg   +2 more
openalex   +1 more source

A Phase I, First‐In‐Human Study of CBA‐1205, an Anti‐DLK1 Monoclonal Antibody, in Patients With Advanced Solid Tumors

Cancer Science, Volume 116, Issue 4, Page 1012-1022, April 2025.
We conducted a Phase I trial of CBA‐1205, a novel monoclonal antibody targeting DLK1, in advanced solid tumors, demonstrating safety and tolerability with no dose‐limiting toxicities. Preliminary efficacy was observed, with six patients achieving stable disease for over 6 months, and sDLK1 was identified as a potential biomarker associated with ...
Yuki Katsuya, Masafumi Ikeda, Takafumi Koyama, Jun Sato, Mao Okada, Nobuaki Matsubara, Chihiro Kondoh, Toru Mukohara, Kazuo Watanabe, Daisuke Kotani, Yoshimi Ogawa, Shose Taoka, Noboru Yamamoto   +12 more
wiley   +1 more source

The prevalence and risk factors of vaginal Candida species and group B Streptococcus colonization in pregnant women attending antenatal care at Hawassa university comprehensive specialized hospital in Hawassa City, Southern Ethiopia. [PDF]

BMC Pregnancy Childbirth
Eskezia A, Teklemichael AM, Alemayehu T.
europepmc   +1 more source

Relevance of Antigenicity of Candida Albicans Growth Phases to Diagnosis of Systemic Candidiasis [PDF]

, 1973
E. G. V. Evans, Malcolm Richardson, Frank C. Odds, K.T. Holland   +3 more
openalex   +1 more source

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study

Clinical and Translational Science, Volume 18, Issue 4, April 2025.
ABSTRACT Properdin is an endogenous positive regulator of the complement alternative pathway (AP). Tarperprumig (ALXN1820), a novel humanized bispecific antibody, binds properdin and albumin and is being developed to treat complement‐mediated diseases.
Avner Sandhu, Tong Shen, Paz Martin Herrero, Chao‐Xing Yuan, Samirah Qureshi, Xiaoyu Jiang, Ye Sheng, Christoph Gasteyger, Yang Dai   +8 more
wiley   +1 more source